What Happened?
Newton, MA-based Karyopharm Appointed Steven Rotman as Senior Vice President of Human Resources
Date of management change: October 15, 2019
Newton, MA-based Karyopharm Appointed Steven Rotman as Senior Vice President of Human Resources
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is an oncology-focused pharmaceutical company dedicated to the discovery, development, and commercialization of novel first-in-class drugs directed against nuclear export and related targets for the treatment of cancer and other major diseases. Karyopharm`s SINE compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1). Karyopharm`s lead compound, XPOVIO™ (selinexor), received accelerated approval from the FDA in July 2019 in combination with dexamethasone as a treatment for patients with heavily pretreated multiple myeloma. A Marketing Authorization Application for selinexor is also currently under review by the European Medicines Agency. In addition to single-agent and combination activity against a variety of human cancers, SINE compounds have also shown biological activity in models of neurodegeneration, inflammation, autoimmune disease, certain viruses and wound-healing. Karyopharm has several investigational programs in clinical or preclinical development.
Steven Rotman is Senior Vice President of Human Resources at Karyopharm. Previously, Steven held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Broussard James, Gordon Glenn, Shim Irene, Gowen Jerry, Cannefax Kelly, Marshall Chris, Tucci Rachelle, Garcia Bob, Baumgartner Steven, Zimmerman Moorie, Overdorff Megan
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.